Back to Search
Start Over
A New Side Effect of Intravitreal Dexamethasone Implant (Ozurdex®)
- Source :
- Case Reports in Ophthalmological Medicine, Vol 2017 (2017)
- Publication Year :
- 2017
- Publisher :
- Wiley, 2017.
-
Abstract
- Dexamethasone implant, 0,7 mg (Ozurdex, Allergan, Inc., Irvine, CA, USA), is drug mostly used in the treatment of the diabetic macular edema and edema related to retinal vein occlusion. By reporting this case we aimed to report a new side effect of 0.7 mg intravitreal dexamethasone implant that has not been reported in the literature before.
- Subjects :
- Ophthalmology
RE1-994
Subjects
Details
- Language :
- English
- ISSN :
- 20906722 and 20906730
- Volume :
- 2017
- Database :
- Directory of Open Access Journals
- Journal :
- Case Reports in Ophthalmological Medicine
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.2cd2bcd62fef45e18c6c000b63d1ada2
- Document Type :
- article
- Full Text :
- https://doi.org/10.1155/2017/6369085